Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study

• Sanne Christine van Kampen ,

  * E-mail: sanne.vankampen@kncvtbc.org

  Affiliation KNCV Tuberculosis Foundation, Central Office, The Hague, Netherlands

  ⨯
• Aigul Tursynbayeva,

  Affiliation KNCV Tuberculosis Foundation, Central Asia Office, Almaty, Kazakhstan

  ⨯
• Aliya Koptleuova,

  Affiliation National Center of Tuberculosis Control, Almaty, Kazakhstan

  ⨯
• Zauresh Murzabekova,

  Affiliation Akmola Regional Tuberculosis Dispensary, Kokshetau, Kazakhstan

  ⨯
• Lyazzat Bigalieva,

  Affiliation East Kazakhstan Regional Tuberculosis Dispensary, Oskemen, Kazakhstan

  ⨯
• Moldir Aubakirova,

  Affiliation Almaty City Tuberculosis Dispensary, Almaty, Kazakhstan

  ⨯
• Svetlana Pak,

  Affiliation KNCV Tuberculosis Foundation, Central Asia Office, Almaty, Kazakhstan

  ⨯
• Susan van den Hof

  Affiliation KNCV Tuberculosis Foundation, Central Office, The Hague, Netherlands

  ⨯